Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastien Lacroix-Desmazes

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
The Journal of Biological Chemistry|July 20, 2007
Antibodies use heme as a cofactor to extend their pathogen elimination activity and to acquire new effector functionsJordan D Dimitrov, Lubka T Roumenina, Virjinia R Doltchinkova, et al.
International Immunology|April 30, 2002
Autoantibodies to heat shock protein 90 in the human natural antibody repertoireAnastas Pashov, Andrey Kenderov, Stanimir Kyurkchiev, et al.
Cellular Immunology|July 3, 2020
Stimulation with FITC-labeled antigens confers B cells with regulatory propertiesCyril Planchais, Julie Rayes, Sandrine Delignat, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|January 27, 2019
The nitrone spin trap 5,5‑dimethyl‑1‑pyrroline N‑oxide binds to toll-like receptor-2-TIR-BB-loop domain and dampens downstream inflammatory signalingMarcos D Muñoz, Lucas J Gutierrez, Sandrine Delignat, et al.
Blood|April 5, 2003
Peptide decoys selected by phage display block in vitro and in vivo activity of a human anti-FVIII inhibitorSylvie Villard, Sebastien Lacroix-Desmazes, Thomas Kieber-Emmons, et al.
Blood Advances|April 9, 2025
Patient anti-FVIII drug antibodies bind preferentially to a subset of FVIII covalent statesDiego Butera, Aster E Pijning, Nathan G Avery, et al.
Haematologica|March 13, 2025
Regulation of immune responses to therapeutic factor VIII by transplacental delivery of Fc-fused immunodominant factor VIII domains or peptidesAlejandra Reyes-Ruiz, Sandrine Delignat, Aurélien Azam, et al.
Plos One|July 30, 2013
Affinity-purified respiratory syncytial virus antibodies from intravenous immunoglobulin exert potent antibody-dependent cellular cytotoxicityNimesh Gupta, Jerome LeGoff, Soulaima Chamat, et al.
Haematologica|December 12, 2024
Binding of therapeutic Fc-fused factor VIII to the neonatal Fc receptor at neutral pH associates with poor half-life extensionAlejandra Reyes-Ruiz, Sandrine Delignat, Aishwarya Sudam Bhale, et al.
Molecular Immunology|October 9, 2009
Kinetics and thermodynamics of interaction of coagulation factor VIII with a pathogenic human antibodyJordan D Dimitrov, Lubka T Roumenina, Sebastien Andre, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
The Journal of Biological Chemistry|July 20, 2007
Antibodies use heme as a cofactor to extend their pathogen elimination activity and to acquire new effector functionsJordan D Dimitrov, Lubka T Roumenina, Virjinia R Doltchinkova, et al.
International Immunology|April 30, 2002
Autoantibodies to heat shock protein 90 in the human natural antibody repertoireAnastas Pashov, Andrey Kenderov, Stanimir Kyurkchiev, et al.
Cellular Immunology|July 3, 2020
Stimulation with FITC-labeled antigens confers B cells with regulatory propertiesCyril Planchais, Julie Rayes, Sandrine Delignat, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|January 27, 2019
The nitrone spin trap 5,5‑dimethyl‑1‑pyrroline N‑oxide binds to toll-like receptor-2-TIR-BB-loop domain and dampens downstream inflammatory signalingMarcos D Muñoz, Lucas J Gutierrez, Sandrine Delignat, et al.
Blood|April 5, 2003
Peptide decoys selected by phage display block in vitro and in vivo activity of a human anti-FVIII inhibitorSylvie Villard, Sebastien Lacroix-Desmazes, Thomas Kieber-Emmons, et al.
Blood Advances|April 9, 2025
Patient anti-FVIII drug antibodies bind preferentially to a subset of FVIII covalent statesDiego Butera, Aster E Pijning, Nathan G Avery, et al.
Haematologica|March 13, 2025
Regulation of immune responses to therapeutic factor VIII by transplacental delivery of Fc-fused immunodominant factor VIII domains or peptidesAlejandra Reyes-Ruiz, Sandrine Delignat, Aurélien Azam, et al.
Plos One|July 30, 2013
Affinity-purified respiratory syncytial virus antibodies from intravenous immunoglobulin exert potent antibody-dependent cellular cytotoxicityNimesh Gupta, Jerome LeGoff, Soulaima Chamat, et al.
Haematologica|December 12, 2024
Binding of therapeutic Fc-fused factor VIII to the neonatal Fc receptor at neutral pH associates with poor half-life extensionAlejandra Reyes-Ruiz, Sandrine Delignat, Aishwarya Sudam Bhale, et al.
Molecular Immunology|October 9, 2009
Kinetics and thermodynamics of interaction of coagulation factor VIII with a pathogenic human antibodyJordan D Dimitrov, Lubka T Roumenina, Sebastien Andre, et al.
Pageof 6